|
|
|
Insider
Information: |
Dere Willard H |
Relationship: |
|
City: |
Thousand Oaks |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
164,053 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,268,003 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
164,053 |
|
|
Total
Value |
$6,268,003 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amgen Inc |
AMGN |
Officer |
2004-12-13 |
9,550 |
|
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-21 |
32,300 |
2016-07-15 |
0 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
Director |
2017-12-11 |
0 |
2017-06-20 |
0 |
Premium* |
|
Radius Health Inc. |
RDUS |
Director |
2022-08-15 |
0 |
2019-02-13 |
0 |
Premium* |
|
Seres Therapeutics, Inc. |
MCRB |
Director |
2022-07-05 |
31,746 |
2022-07-05 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
Director |
2024-01-02 |
39,182 |
2023-04-03 |
0 |
Premium* |
|
Metagenomi, Inc. |
MGX |
|
2024-02-08 |
51,275 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MCRB |
Seres Therapeutics, Inc. |
Director |
|
2022-07-05 |
4 |
A |
$3.15 |
$100,000 |
D/D |
31,746 |
31,746 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2019-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,800 |
4,800 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2019-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
10,300 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2019-04-16 |
4 |
AS |
$22.22 |
$37,330 |
D/D |
(1,680) |
8,620 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2020-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
14,120 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2020-02-26 |
4 |
AS |
$17.95 |
$34,554 |
D/D |
(1,925) |
12,195 |
0 |
% |
|
RDUS |
Radius Health Inc. |
Director |
|
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
17,695 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,500 |
23,195 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2022-08-15 |
4 |
D |
$10.00 |
$18,950 |
D/D |
(1,895) |
0 |
0 |
- |
|
RDUS |
Radius Health Inc. |
Director |
|
2022-08-15 |
4 |
D |
$10.00 |
$213,000 |
D/D |
(21,300) |
1,895 |
0 |
- |
|
OCRX |
Ocera Therapeutics Inc |
Director |
|
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
OCRX |
Ocera Therapeutics Inc |
Director |
|
2017-12-11 |
4 |
D |
$1.52 |
$19,000 |
D/D |
(12,500) |
0 |
0 |
- |
|
MGX |
Metagenomi, Inc. |
|
|
2024-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
51,275 |
|
- |
|
MRSN |
Mersana Therapeutics, Inc... |
Director |
|
2023-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,375 |
3,375 |
0 |
- |
|
MRSN |
Mersana Therapeutics, Inc... |
Director |
|
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
14,467 |
17,842 |
0 |
- |
|
MRSN |
Mersana Therapeutics, Inc... |
Director |
|
2023-07-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,217 |
22,059 |
0 |
- |
|
MRSN |
Mersana Therapeutics, Inc... |
Director |
|
2023-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
11,011 |
33,070 |
0 |
- |
|
MRSN |
Mersana Therapeutics, Inc... |
Director |
|
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,112 |
39,182 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2016-07-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
2,640 |
2,640 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2016-07-15 |
4 |
A |
$0.00 |
$0 |
D/D |
3,300 |
3,300 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2017-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,050 |
4,690 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
8,990 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2019-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,430 |
13,420 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2020-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,300 |
17,720 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2020-06-26 |
4 |
AS |
$123.61 |
$547,592 |
D/D |
(4,430) |
13,290 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|